Medicamen Organics Limited (NSE: MEDIORG) is a New Delhi, Delhi-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹30 Cr, it ranks #4,150 by market cap among the 6,197 Indian listed companies on FinBizNet, and #22 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹23.65 (as of 16 Nov 2026), the share price is 26.1% below its 52-week high of ₹32.00 and 23.8% above its 52-week low of ₹19.10. The share price is down 22.3% over one year and up 1.0% over three months.
| Current Price | ₹23.65 |
|---|---|
| Market Cap | ₹30 Cr |
| NSE Symbol | MEDIORG |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Manufacturing Services |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -13.66% |
| Return on Assets | -5.22% |
| 52-Week Range | ₹19.10 – ₹32.00 |
| 1-Year Price Change | -22.3% |
| 3-Month Price Change | +1.0% |
| Beta (1Y) | 0.99 |
| Headquarters | New Delhi, Delhi |
| Website | www.medicamenorganics.com |
Promoters held 54.89% of Medicamen Organics Limited's shares as of Jun 2026, against 59.73% in Mar 2025 (−4.84 percentage points).
Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products under the LOIRE brand. The company markets its products to government and private institutions as contract manufacturer/third party manufacturer; and private pharmaceutical companies through third party distributors or on loan license basis across India; African, CIS, and Southeast Asian Countries; and internationally. Medicamen Organics Limited was formerly known as Panchdeep Pharmaceuticals Limited and changed its name to Medicamen Organics Limited
1. Pharmaceuticals-This segment manufactures pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Torrent Pharma Ltd. | ₹1,79,494 Cr | 73.6 | 16.98% | ₹4,979 Cr | +30.4% |
| Aether Industries Limited | ₹21,710 Cr | 101.8 | 9.81% | ₹347 Cr | +127.8% |
| Alivus Life Sciences Ltd | ₹17,862 Cr | 31.5 | 18.36% | ₹682 Cr | +64.0% |
| Aarti Pharmalabs Ltd | ₹8,374 Cr | 52.5 | 8.49% | ₹610 Cr | +15.4% |
| Solara Active Pharma Sciences Limited | ₹3,225 Cr | n/m | -0.63% | ₹417 Cr | +22.1% |
| Sai Parenteral's Limited | ₹2,235 Cr | 115.8 | 2.88% | ₹195 Cr | — |
| KRM Ayurveda Limited | ₹521 Cr | 25.9 | 17.54% | ₹32 Cr | — |
| Trident Lifeline Limited | ₹511 Cr | 26 | — | — | +37.6% |
| Medicamen Organics Limited | ₹30 Cr | n/m | -13.66% | — | -22.3% |
Listed by market capitalisation. Ratios are shown for context only.
Medicamen Organics Limited is trading at ₹23.65, with a market capitalisation of ₹30 Cr.
Medicamen Organics Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).
Medicamen Organics Limited has a return on equity of -13.66%.
Medicamen Organics Limited is listed on the NSE under the symbol MEDIORG.
Medicamen Organics Limited's share price is down 22.3% over one year and up 1.0% over three months. Its 52-week range is ₹19.10 to ₹32.00.
Promoters held 54.89% of Medicamen Organics Limited's shares as of Jun 2026, against 59.73% in Mar 2025 (−4.84 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.